1. Home
  2. CMC vs KRYS Comparison

CMC vs KRYS Comparison

Compare CMC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Metals Company

CMC

Commercial Metals Company

HOLD

Current Price

$74.93

Market Cap

8.5B

Sector

Industrials

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$275.88

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMC
KRYS
Founded
1915
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.8B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CMC
KRYS
Price
$74.93
$275.88
Analyst Decision
Buy
Strong Buy
Analyst Count
10
10
Target Price
$71.10
$297.60
AVG Volume (30 Days)
1.1M
269.9K
Earning Date
04-10-2026
05-18-2026
Dividend Yield
0.97%
N/A
EPS Growth
N/A
128.00
EPS
1.58
6.84
Revenue
$7,918,430,000.00
$389,130,000.00
Revenue This Year
$17.75
$44.50
Revenue Next Year
$6.63
$34.79
P/E Ratio
$47.20
$39.84
Revenue Growth
25.57
33.94
52 Week Low
$37.92
$123.03
52 Week High
$84.87
$298.30

Technical Indicators

Market Signals
Indicator
CMC
KRYS
Relative Strength Index (RSI) 41.84 53.06
Support Level $74.66 $258.34
Resistance Level $75.03 $293.60
Average True Range (ATR) 2.36 12.40
MACD -1.07 -1.12
Stochastic Oscillator 10.49 50.55

Price Performance

Historical Comparison
CMC
KRYS

About CMC Commercial Metals Company

Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group. The majority of revenue is from North America Steel Group.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: